Already 182 people have seen this company's branding but they do not have any followers.In average the company has been rated 4.5 points but has not been commented.

's activity report 2022

About the company

The main activity of Põlva Uus Apteek OÜ is the retail sale of medicines, medicine-like products, dietary supplements and medical technology. The company has 7 pharmacies along with branch pharmacies.

Põlva Uus Apteek OÜ pharmacies use the SÜDAMEAPTEEGI franchise concept and operate under the SÜDAMEAPTEEGI brand. Such operation ensures the provision of high-quality pharmacy services to customers.

The sales revenue for the 2022 financial year was 5,513.7 thousand EUR (the sales revenue for the 2021 financial year was 5,063.5 thousand EUR). The growth in sales revenue in the 2022 financial year was partly due to people using rapid tests for self-testing in case of suspicion of Covid-19 infection.

The Russia-Ukraine war that began in 2022 did not significantly affect the company's result.

Plans for the new financial year

Increasing the number of regular customers through improving the level of customer service and thereby increasing sales revenue.

Team

The board of Põlva Uus Apteek OÜ consists of 1 member. No remuneration has been paid to the board member. The total labor costs for the 2022 financial year were 646.4 thousand EUR and the number of full-time equivalent employees was 24. In 2021, the total labor costs were 539.7 thousand EUR and the number of full-time equivalent employees was 23.

Key financial ratios

Financial ratios 2022 2021

Sales revenue, thousand EUR 5,513.70 5,063.50

EBITDA, thousand EUR -2.1 -31.4 = Operating profit before depreciation

EBITDA margin, % 0.00% -0.60% = Operating profit before depreciation / Sales revenue

Net profit margin, % 0.00% -0.50% = Net profit / Sales revenue

Return on assets, % 0.10% -2.50% = Net profit / Assets

Short-term liabilities coverage ratio 0.9 0.8 = Current assets / Short-term liabilities

Working capital, thousand EUR -152 -213.3 = Current assets - Short-term liabilities

Equity ratio, % 0.30% 0.20% = Equity / Total assets